TY - JOUR AU - Dantas-Torres, F. AU - Brandao-Filho, S. P. PY - 2006 DA - 2006// TI - Visceral leishmaniosis in Brazil: revisiting paradigms of epidemiology and control JO - Rev Inst Med trop S Paulo VL - 48 UR - https://doi.org/10.1590/S0036-46652006000300007 DO - 10.1590/S0036-46652006000300007 ID - Dantas-Torres2006 ER - TY - JOUR AU - Palatnik de Sousa, C. B. AU - Santos, W. R. AU - Franc, Ĵ. C. AU - Silva, A. AU - Costa, R. T. AU - Reis, A. B. PY - 2001 DA - 2001// TI - Impact of canine control on the epidemiology of canine and human visceral leishmaniosis in brazil Am JO - J Trop Med Hyg VL - 65 ID - Palatnik de Sousa2001 ER - TY - JOUR AU - Manna, L. AU - Reale, S. AU - Vitale, F. AU - Picillo, E. AU - Pavone, L. M. AU - Gravino, A. E. PY - 2008 DA - 2008// TI - Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol JO - Vet J VL - 177 UR - https://doi.org/10.1016/j.tvjl.2007.04.013 DO - 10.1016/j.tvjl.2007.04.013 ID - Manna2008 ER - TY - JOUR AU - Mirò, G. AU - Cardoso, L. AU - Pennisi, M. G. AU - Oliva, G. AU - Baneth, G. PY - 2008 DA - 2008// TI - Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part two JO - Trends Parasitol VL - 24 UR - https://doi.org/10.1016/j.pt.2008.05.003 DO - 10.1016/j.pt.2008.05.003 ID - Mirò2008 ER - TY - JOUR AU - Dorlo, T. P. C. AU - Balasegaram, M. AU - Beijnen, J. H. AU - Vries, P. PY - 2012 DA - 2012// TI - Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniosis JO - J Antimicrob Chemother VL - 67 UR - https://doi.org/10.1093/jac/dks275 DO - 10.1093/jac/dks275 ID - Dorlo2012 ER - TY - JOUR AU - Sundar, S. AU - Sinha, P. AU - Jha, T. K. AU - Chakravarty, J. AU - Rai, M. AU - Kumar, N. PY - 2013 DA - 2013// TI - Oral miltefosine for Indian post-Kala-Azar dermal leishmaniosis: a randomized trial JO - Trop Med Int Healt VL - 18 UR - https://doi.org/10.1111/tmi.12015 DO - 10.1111/tmi.12015 ID - Sundar2013 ER - TY - JOUR AU - Sundar, S. AU - Singh, A. AU - Rai, M. AU - Prajapati, V. K. AU - Singh, A. K. AU - Ostyn, B. PY - 2012 DA - 2012// TI - Efficacy of miltefosine in the treatment of visceral leishmaniosis in India after a decade of use JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis474 DO - 10.1093/cid/cis474 ID - Sundar2012 ER - TY - JOUR AU - Ostyn, B. AU - Hasker, E. AU - Dorlo, T. P. C. AU - Rijal, S. AU - Dujardin, J. C. AU - Boelaert, M. PY - 2014 DA - 2014// TI - Failure of miltefosine treatment for visceral leishmaniosis in children and men in south-East Asia JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0100220 DO - 10.1371/journal.pone.0100220 ID - Ostyn2014 ER - TY - JOUR AU - Manna, L. AU - Vitale, F. AU - Reale, S. AU - Picillo, E. AU - Neglia, G. AU - Vescio, F. PY - 2009 DA - 2009// TI - Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis JO - Vet J VL - 182 UR - https://doi.org/10.1016/j.tvjl.2008.08.009 DO - 10.1016/j.tvjl.2008.08.009 ID - Manna2009 ER - TY - JOUR AU - Travi, B. L. PY - 2014 DA - 2014// TI - Ethical and epidemiological dilemmas in the treatment of dogs for visceral leishmaniosis in latin America JO - Biomedica. VL - 34 UR - https://doi.org/10.7705/biomedica.v34i1.2153 DO - 10.7705/biomedica.v34i1.2153 ID - Travi2014 ER - TY - JOUR AU - Muniz-Junqueira, M. I. AU - Paula-Coelho, V. N. PY - 2008 DA - 2008// TI - Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-alpha production, but only via TNF-alpha it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro JO - Int Immunopharmacol VL - 8 UR - https://doi.org/10.1016/j.intimp.2008.07.011 DO - 10.1016/j.intimp.2008.07.011 ID - Muniz-Junqueira2008 ER - TY - JOUR AU - Francino, O. AU - Altet, L. AU - Sanchez-Robert, E. AU - Rodriguez, A. AU - Solano-Gallego, L. AU - Alberola, J. PY - 2006 DA - 2006// TI - Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis JO - Vet Parasitol VL - 137 UR - https://doi.org/10.1016/j.vetpar.2006.01.011 DO - 10.1016/j.vetpar.2006.01.011 ID - Francino2006 ER - TY - JOUR AU - Koutinas, A. F. AU - Saridomichelakis, M. N. AU - Mylonakis, M. E. AU - Leontides, L. AU - Polizopoulou, Z. AU - Billinis, C. PY - 2001 DA - 2001// TI - A randomized, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis JO - Vet Parasitol VL - 98 UR - https://doi.org/10.1016/S0304-4017(01)00399-5 DO - 10.1016/S0304-4017(01)00399-5 ID - Koutinas2001 ER - TY - JOUR AU - Torres, M. AU - Bardagui, M. AU - Roura, X. AU - Zanna, G. AU - Ravera, I. AU - Ferrer, L. PY - 2011 DA - 2011// TI - Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol JO - Vet J VL - 188 UR - https://doi.org/10.1016/j.tvjl.2010.05.025 DO - 10.1016/j.tvjl.2010.05.025 ID - Torres2011 ER - TY - JOUR AU - Mateo, M. AU - Maynard, L. AU - Vischer, C. AU - Bianciardi, P. AU - Mirò, G. PY - 2009 DA - 2009// TI - Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis JO - Parasitol Res VL - 105 UR - https://doi.org/10.1007/s00436-009-1375-3 DO - 10.1007/s00436-009-1375-3 ID - Mateo2009 ER - TY - JOUR AU - Solano-Gallego, L. AU - Koutinas, A. AU - Miró, G. AU - Cardoso, L. AU - Pennisi, M. G. AU - Ferrer, L. PY - 2009 DA - 2009// TI - Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis JO - Vet Parasitol VL - 165 UR - https://doi.org/10.1016/j.vetpar.2009.05.022 DO - 10.1016/j.vetpar.2009.05.022 ID - Solano-Gallego2009 ER - TY - JOUR AU - Poot, J. AU - Rogers, M. E. AU - Bates, P. A. AU - Vermeulen, A. PY - 2005 DA - 2005// TI - Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs JO - Vet Parasitol VL - 130 UR - https://doi.org/10.1016/j.vetpar.2005.03.002 DO - 10.1016/j.vetpar.2005.03.002 ID - Poot2005 ER - TY - JOUR AU - Denerolle, P. AU - Bourdoiseau, G. PY - 1999 DA - 1999// TI - Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniosis (96 cases) JO - J Vet Intern Med VL - 13 UR - https://doi.org/10.1111/j.1939-1676.1999.tb01455.x DO - 10.1111/j.1939-1676.1999.tb01455.x ID - Denerolle1999 ER - TY - JOUR AU - Mirò, G. AU - Oliva, G. AU - Cruz, I. AU - Canavate, C. AU - Mortarino, M. AU - Vischer, C. PY - 2009 DA - 2009// TI - Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis JO - Vet Dermatol VL - 20 UR - https://doi.org/10.1111/j.1365-3164.2009.00824.x DO - 10.1111/j.1365-3164.2009.00824.x ID - Mirò2009 ER - TY - JOUR AU - Manna, L. AU - Reale, S. AU - Viola, E. AU - Vitale, F. AU - Foglia, M. V. AU - Pavone, L. M. PY - 2006 DA - 2006// TI - Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs JO - Vet Parasitol VL - 142 UR - https://doi.org/10.1016/j.vetpar.2006.06.028 DO - 10.1016/j.vetpar.2006.06.028 ID - Manna2006 ER - TY - JOUR AU - Abranches, P. AU - Fernandes, J. P. PY - 1991 DA - 1991// TI - Quality control methods in sero-immunologic tests for infectious diseases JO - Acta Med Port VL - 4 ID - Abranches1991 ER - TY - JOUR AU - Chappuis, F. AU - Sundar, S. AU - Hailu, A. AU - Ghalib, H. AU - Rijal, S. AU - Peeling, R. W. PY - 2007 DA - 2007// TI - Visceral leishmaniosis: what are the needs for diagnosis, treatment and control? JO - Nat Rev Microbiol. VL - 5 UR - https://doi.org/10.1038/nrmicro1748 DO - 10.1038/nrmicro1748 ID - Chappuis2007 ER - TY - JOUR AU - Ferrer, L. AU - Aisa, M. J. AU - Roura, X. AU - Portús, M. PY - 1995 DA - 1995// TI - Serological diagnosis and treatment of canine leishmaniosis JO - Vet Rec. VL - 136 UR - https://doi.org/10.1136/vr.136.20.514 DO - 10.1136/vr.136.20.514 ID - Ferrer1995 ER - TY - JOUR AU - Reis, A. B. AU - Martins-Filho, O. A. AU - Teixeira-Carvalho, A. AU - Carvalho Wilson, M. G. AU - Francâ-Silva, J. C. AU - Giunchetti, R. C. PY - 2006 DA - 2006// TI - Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniosis JO - ResVet Sci. VL - 81 ID - Reis2006 ER - TY - JOUR AU - Lebrun-Vignes, B. AU - Valeyrie-Allanore, L. PY - 2014 DA - 2014// TI - Cutaneous adverse drug reactions JO - Rev Med Interne. VL - 36 UR - https://doi.org/10.1016/j.revmed.2014.10.004 DO - 10.1016/j.revmed.2014.10.004 ID - Lebrun-Vignes2014 ER - TY - STD TI - Lin CH, Chen JK, Ko TM, Wei CY, Wu JY, Chung WH, et al. Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction. J Allergy Clin Immunol. 2014; in press. ID - ref26 ER - TY - JOUR AU - Jung, J. W. AU - Kim, D. K. AU - Park, H. W. AU - Oh, K. H. AU - Joo, K. W. AU - Kim, Y. S. PY - 2015 DA - 2015// TI - An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing JO - Genet Med. VL - 17 ID - Jung2015 ER -